Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Ms. Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Central University of Punjab | India

Ms. Shivani Chib is an emerging researcher in the field of pharmacology, specializing in neurodegenerative diseases with a particular focus on Parkinson’s disease and the therapeutic potential of phytoconstituents. Currently pursuing her Ph.D. at the Central University of Punjab, Bathinda, she has contributed extensively through high-impact publications, innovative patents, international presentations, and active peer-reviewing for reputed journals. With multiple national and international awards, she stands out as a dedicated woman researcher committed to advancing pharmacological science and drug discovery.

Professional Profile

Scopus

Google Scholar

Education

Ms. Shivani Chib is currently pursuing her doctoral research in Pharmacology at the Central University of Punjab, Bathinda, under the guidance of Dr. Randhir Singh. Her Ph.D. research centers on Parkinson’s disease and the therapeutic potential of bioactive phytoconstituents, reflecting her dedication to translational research in neuropharmacology. Before her doctoral studies, she completed her Master of Pharmacy in Pharmacology from ISF College of Pharmacy, where she excelled academically and carried out research in experimental pharmacology. Her academic journey began with a Bachelor of Pharmacy in Pharmaceutical Sciences from Sri Sai College of Pharmacy. This progression in higher education reflects not only her intellectual growth but also her determination to specialize in pharmacology and contribute to the field of neuroscience.

Experience

Her professional journey as a researcher began during her postgraduate studies, where she worked as a Research Scholar and focused on understanding drug mechanisms and neuroprotective agents. Currently, as a Ph.D. Research Scholar at the Central University of Punjab, she is engaged in cutting-edge research on Parkinson’s disease, with particular emphasis on dopaminergic neuronal death and the role of phytochemicals such as luteolin and wogonin. She has also contributed as a reviewer for multiple Springer Nature journals, a role that reflects her expertise and recognition in the scientific community. Her active engagement in national and international conferences, combined with her innovative experimental approaches, illustrates her wide-ranging experience in both research and academic settings.

Research Interest

Her research interests revolve around neuropharmacology, neurodegenerative disorders, natural product-based drug discovery, and cognitive impairments associated with aging. She has a deep focus on elucidating the mechanisms of dopaminergic neuronal death in Parkinson’s disease and identifying bioactive phytoconstituents like luteolin and wogonin as potential therapeutic agents. Additionally, her work extends to exploring CNS toxicity of chemotherapeutics, marine functional foods, metabolic syndromes, and the cross-talk between central nervous and cardiovascular systems.

Awards and Recognitions

Ms. Shivani Chib has received numerous awards and recognitions throughout her career, including Best Working Model Award, Best Poster Awards at national and international conferences, and the prestigious GPAT fellowship. She has been awarded multiple international travel grants, including from the Movement Disorder Society and the Anusandhan National Research Foundation, enabling her to present her work globally, including at conferences in the USA and Japan. She has also received certificates of excellence in peer reviewing from Springer Nature and BP International. Her innovation in neuroscience is further highlighted by her registered patents on novel laboratory apparatuses, reflecting her inventive approach to experimental pharmacology.

Publications

Ms. Shivani Chib has published widely in reputed international journals, with her contributions cited in several scholarly works. Selected publications include:

Title: Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Journal: Ageing Research Reviews
Published on: 2024
Citation: 49

Title: Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
Journal: Neurotoxicology and Teratology
Published on: 2022
Citation: 35

Title: Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline
Journal: Ageing Research Reviews
Published on: 2023
Citation: 21

Title: Treatment of diabetic complications: do flavonoids holds the keys?
Journal: Critical Reviews in Food Science and Nutrition
Published on: 2024
Citation: 16

Title: Paradigms and success stories of natural products in drug discovery against neurodegenerative disorders (NDDs)
Journal: Current Neuropharmacology
Published on: 2024
Citation: 15

Title: Microbiota-brain-gut-Axis relevance to Parkinson’s disease: potential therapeutic effects of probiotics
Journal: Current Pharmaceutical Design
Published on: 2022
Citation: 11

Title: Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease
Journal: Phytotherapy Research
Published on: 2025
Citation: 10

Conclusion

Ms. Shivani Chib has established herself as a promising woman researcher in pharmacology through her strong academic background, impactful publications, innovative patents, and global recognitions. Her work in exploring the therapeutic applications of phytoconstituents against neurodegenerative disorders has the potential to open new pathways for safer and more effective treatments. With her commitment to excellence, interdisciplinary approach, and growing global presence, she exemplifies the qualities of a future leader in pharmacological sciences. She is therefore highly deserving of the Women Researcher Award, which would further empower her to continue contributing to scientific progress and global healthcare solutions.

Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Assoc. Prof. Dr. Alemayehu Toma | Toxicology and Pharmaceutical Science | Best Researcher Award

Hawassa University College of Medicine and Health Sciences | Ethiopia

Dr. Alemayehu Toma is an Associate Professor of Pharmacology at Hawassa University, Ethiopia, and an accomplished researcher whose work bridges pharmacological science with public health impact. His professional career reflects an unwavering dedication to advancing medical knowledge, improving patient outcomes, and addressing pressing health challenges in both local and global contexts. Over his career, he has built an outstanding reputation for his research in HIV/AIDS treatment outcomes, pharmacovigilance, nutrition-related interventions, and the safety and efficacy of medicinal plants. With 45 peer-reviewed publications and more than 3,900 citations on Google Scholar, his research has significantly influenced both scientific literature and healthcare practice.

Professional Profile

Google Scholar

ORCID

Education

Dr. Toma’s academic path demonstrates a progressive commitment to mastery in pharmacology and medical science. He earned his Ph.D. in Pharmacology from Addis Ababa University, preceded by a Master’s degree in Pharmacology from the same institution, and a Bachelor of Pharmacy from Jimma University. To further enhance his educational contributions, he obtained a Higher Diploma in Pedagogy from Hawassa University, equipping him with the expertise to deliver effective teaching and mentorship in higher education. His academic background integrates deep pharmacological knowledge with practical clinical insight and refined pedagogical skill.

Experience

Dr. Toma’s professional career spans teaching, research, clinical service, and academic leadership. At Hawassa University, he held the role of Associate Professor of Pharmacology in the College of Medicine and Health Sciences, where he was also Head of the Quality Assurance Office. He played a pivotal role in maintaining academic standards, developing research capacity, and ensuring the quality of medical education. He has also served as an Assistant Professor of Pharmacology at Komar University of Science and Technology in Iraq, where he contributed to curriculum development and supervised postgraduate theses. His work as a licensed pharmacy specialist reflects his hands-on involvement in patient care, linking academic expertise with clinical practice.

Research Interest

Dr. Toma’s research interests are diverse but strongly interconnected, focusing on areas where pharmacological science directly impacts human health. His core areas include HIV/AIDS treatment outcomes and comorbidities, the effects of pharmacological interventions on organ systems, antidiabetic and antimicrobial activities of medicinal plants, nutritional status among vulnerable populations, and epidemiological studies of chronic and infectious diseases. He also contributes to multi-country global health collaborations, such as disease burden mapping, which inform policy and public health programs. His work is characterized by methodological rigor, translational relevance, and a commitment to addressing real-world medical challenges.

Awards and Recognition

Dr. Toma’s contributions to pharmacology and public health have been acknowledged in prestigious journals including The Lancet, BMJ Open, Scientific Reports, and BMC Infectious Diseases. His h-index of 19 is evidence of sustained research influence, while his work’s consistent citation by peers shows its enduring value. His collaborative publications with international research networks further underscore his role as a key contributor to global health science.

Publications

Title: Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Journal: The Lancet Respiratory Medicine
Published on: 2020
Citation: 2126

Title: Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the …
Journal: The Lancet HIV
Published on: 2019
Citation: 560

Title: Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease …
Journal: The Lancet
Published on: 2020
Citation: 152

Title: Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves
Journal: BMC Complementary and Alternative Medicine
Published on: 2014
Citation: 123

Title: Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats
Journal: BMC Complementary and Alternative Medicine
Published on: 2015
Citation: 121

Title: Phytochemistry and pharmacological activities of Moringa oleifera
Journal: International Journal of Pharmacognosy
Published on: 2014
Citation: 94

Title: Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis for the Global Burden of …
Journal: Occupational and Environmental Medicine
Published on: 2020
Citation: 76

Title: Antimicrobial resistance profile of Staphylococcus aureus isolates isolated from ear discharges of patients at University of Hawassa comprehensive specialized …
Journal: BMC Pharmacology and Toxicology
Published on: 2017
Citation: 74

Conclusion

Dr. Alemayehu Toma’s career stands as a model of academic excellence, research productivity, and societal impact. His studies have provided crucial insights into the management of HIV/AIDS, nutrition in vulnerable groups, medicinal plant pharmacology, and the global burden of diseases. He has consistently demonstrated the ability to translate research findings into actionable recommendations for health systems, contributing to policy change and improved clinical outcomes. His leadership in academia, commitment to mentoring emerging scholars, and active collaboration in international research initiatives make him an outstanding candidate for the Best Researcher Award. This recognition would not only honor his past achievements but also encourage further contributions that can transform healthcare practice in resource-limited settings worldwide.